Brit Mollenhauer, MD, is a physician-scientist and professor at the University Medical Center Göttingen (UMG). She is head of translational science at the Movement Disorders Center of the Paracelsus-Elena-Klinik, Kassel, Germany. She completed neurology training at UMG and a postdoctoral fellowship at Harvard Medical School. She has developed a translational research program focused on developing biomarkers for diagnosing early and prodromal disease stages, monitoring the progression of Parkinson’s disease (PD) and performing deep phenotyping. Dr. Mollenhauer has launched several observational cohorts, including the De Novo PD (DeNoPa) cohort based in Kassel, to better understand the natural history of PD and disease variants as well as their prodromal stages. Her interdisciplinary research program spans the pathophysiology, epidemiology and deep phenotyping of PD. Dr. Mollenhauer has received several awards and also serves on the executive scientific advisory board of the Parkinson’s Progression Marker Initiative of The Michael J. Fox Foundation.